Modeling the Dementia Epidemic

CNS Neuroscience and Therapeutics

Volumn 18, Issue 2, 2012, Pages 175-181

  Treves, T A ^a   Korczyn, A D ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; Behavioral neurology; Dementia; Epidemiology

Indexed keywords

APOLIPOPROTEIN E4; MITOCHONDRIAL PROTEIN; TOMM40 PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALZHEIMER DISEASE; CAUSE OF DEATH; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EPIDEMIC; GENETIC RISK; GEOGRAPHIC DISTRIBUTION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MORTALITY; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PREVALENCE; REVIEW; SMOKING; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; DEMENTIA; EPIDEMICS; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 84856789390     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00242.x     Document Type: Review

References (125)

1. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005;366:2112-2117.
2. Ott A, Breteler MB, van Harskamp F, Claus JJ, Van Der Cammen TJM, Grobbee DE, Hofman A. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam Study. BMJ 1995;310:970-973.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 2000.
4. Neary D, Snowdon JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
5. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005;65:1863-1872.
6. Bibl M, Mollenhauer B, Lewczuk P, et al. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Mol Psychiatry 2007;12:671-680.
7. Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engleborghs S. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Neurochem Int 2009;55:214-218.
8. Steinacker P, Hendrich C, Sperfeld AD, et al. TDP-43 in cerebrospinal fluid of patients with Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Arch Neurol 2008;65:1481-1487.
9. Kapaki E, Paraskevas GP, Papageorgiou SG, et al. Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord 2008;22:47-53.
10. Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 2000;57:347-351.
11. Hutchinson AD, Mathias JL. Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: A meta-analytic review. J Neurol Neurosurg Psychiatry 2007;78:917-928.
12. Korczyn AD. The complex nosological concept of vascular dementia. J Neurol Sci 2002;203-204:3-6.
13. Jellinger KA. Morphologic diagnosis of "vascular dementia": A critical update. J Neurol Sci 2008;270:1-12.
14. Fernando MS, Ince PG; for the MRC Cognitive Function and Ageing Neuropathology Study Group. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 2004;226:13-17.
15. Skoog I, Lernfelt B, Landhal S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
16. Stewart R. Cardiovascular factors in Alzheimer's disease. J Neurol neurosurg Psychiatry 1998;65:143-147.
17. Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13(Suppl 3):S106-S114.
18. De la Torre JC. Cerebrovascular and cardiovascular pathology in Alzheimer's disease. Int Rev Neurobiol 2009;84:35-48.
19. Andin U, Gustafson L, Passant U, Brun A. A clinico-pathological study of heart and brain lesions in vascular dementia. Dementia 2005;19:222-228.
20. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
21. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
22. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
23. Haroutunian V, Schainder-Beeri M, Schmeidler J, et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 2008;65:1211-1217.
24. Savva GM, Wharton SB, Ince PG, Forster G, Mattiews FE, Brayne C. Age, neuropathology and dementia. NEJM 2009;360:2302-2309.
25. Berg L, McKeel, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex and apolipoprotein E genotype. Arch Neurol 1998;55:326-335.
26. Nelson PT, Jicha JA, Schmitt FA, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: Neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol 2007;66:1136-1146.
27. Snowdon DA. Aging and Alzheimer's disease: Lessons from the Nun Study. Gerontologist 1997;37:150-156.
28. Price L, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-368.
29. Price JL, van Duijn CM, Chandra V. Neuropathology of nondemented aging: Resumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009;30:1026-1036.
30. Erten-Lyons D, Woltjer RL, Dodge H, et al. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 2009;72:354-360.
31. Terry RD, Katzman R. Life span and synapses: Will there be a primary senile dementia? Neurobiol Aging 2001;22:347-348.
32. Goulding JM, Signorini DF, Chatterjee S, et al. Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. J Neurol Neurosurg Psychiatry 1999;67:654-657.
33. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007;69:2197-2204.
34. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. JAMA 1997;277:813-817.
35. Suter O-C, Sunthorn T, Kraftsik R, Straubel J, Darekar P, Khalili K, Miklossy J. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33:1986-1992.
36. Korczyn AD, Vakhapova V. The prevention of the dementia epidemic. J Neurol Sci 2007;257:2-4.
37. Ebly EM, Parhad IM, Hogan DB, Fung TS. Prevalence and types of dementia in the very old: Results from the Canadian Study of Health and aging. Neurology 1994;44:1593-1600.
38. Von Strauss E, Viitanen M, De Ronchi D, Winblad Bengt, Fratiglioni L. Aging and the occurrence of dementia: Findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol 1999;56:587-592.
39. Wernicke TF, Reischies FM. Prevalence of dementia in old age: Clinical diagnoses in subjects aged 95 years and older. Neurology 1994;44:250-253.
40. Ritchie K, Kildea D. Is senile dementia "age-related" or "ageing-related"? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 1995;346:931-934.
41. Bornstein NM, Gur AY, Treves TA, et al. Do silent brain infarctions predict the development of dementia after first ischemic stroke? Stroke 1996;25:904-905.
42. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005;4:752-759.
43. Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia. Age-dependent incidence, prevalence and mortality in the Old Old. Arch Intern Med 1991;151:989-992.
44. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 1997;48:132-138.
45. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 2000;54:2072-2077.
46. Gao S, Hendrie C, Hall KS, Hui S. The relationship between age, sex, and the incidence of dementia and Alzheimer disease. Arch Gen Psychiatry 1998;55:809-815.
47. Hall CB, Verghese J, Sliwinski, Chen Z, Katz M, Derby C, Lipton RB. Dementia incidence may increase more slowly after age 90. Neurology 2005;65:882-886.
48. Miech RA, Breitner JCS, Zandi PP, Khachaturian AS, Anthony JC, Mayer L; for the Cache County Study Group. Incidence of AD may decline in the early 90s for men, later for women. Neurology 2002;58:209-218.
49. Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old: The 90+ study. Ann Neurol 2010;67:114-121.
50. Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framinggham Study. Neurology 1997;49:498-1504.
51. Beiser A, D'Agostino RB, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Statist Med 2000;19:1495-1522.
52. Breitner JC, Haneuse SJ, Walker R, et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 2009;72:1899-1905.
53. Desmond DW, Moroney JT, Sano M, Stern Y, Merino JG. Incidence of dementia after stroke: Results of a longitudinal study. Stroke 2002;33:2254-2262.
54. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham Study. Stroke 2006;37:345-350.
55. Savva GM, Stephan BCM; for the Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia. A systematic review. Stroke 2010;41:e41-e46.
56. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol 2009;8:973-975.
57. Molsa PK, Marttila RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 1986;74:103-107.
58. Barclay LL, Zemcov A, Blass JP, Sansone J. Survival in Alzheimer's disease and vascular dementias. Neurology 1985;35:834-840.
59. Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y. Survival in Alzheimer's disease. Neurology 2008;71:1489-1495.
60. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. NEJM 2001;344:1111-1116.
61. Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 2003;60:85-90.
62. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 2005;229-230:43-49.
63. Kammoun S, Gold G, Bouras C, Giannakopoulos P, McGee W, Herrmann F, Michel JP. Immediate causes of death of demented and non-demented elderly. Acta Neurol Scand Suppl 2000;176:96-99.
64. Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol 2009;16:488-492.
65. Attems J, Konig C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients: An autopsy study of 308 cases. J Alzheimers Dis 2005;8:57-62.
66. Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999;53:1992-1997.
67. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001;153:132-136.
68. Brookmeyer R, Corrada MM, Curriero FC, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002;59:1764-1767.
69. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
70. Moritz DJ, Petitti DB. Association of education with reported age of onset and severity of Alzheimer's disease at presentation: Implications for the use of clinical samples. Am J Epidemiol 1993;137:456-462.
71. Bowler JV, Munoz DG, Merskey H, Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;65:184-196.
72. Del Ser T, Hachinski V, Merskey H, Munoz DG. An autopsy-verified study of the effect of education on degenerative dementia. Brain 1999;122:2309-2319.
73. Bonaiuto S, Rocca WA, Lippi A, Giannandrea E, Mele M, Cavarzeran F, Amaducci L. Education and occupation as risk factors for dementia: A population-based case-control study. Neuroepidemiol 1995;14:101-109.
74. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
75. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45:1707-1712.
76. Hall CB, Lipton RB, Sliwinski M, Katzby Derby CA, Verghese J. Cognitive activities delay onset of memory decline in persons who develop dementia. Neurology 2009; 73:356-361.
77. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 2007;69:1911-1920.
78. Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. NEJM 2003;348:2508-2516.
79. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
80. Chapman J, Wang N, Treves TA, Korczyn AD, Bornstein NM. ACE, MTHFR, Factor V Leiden and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998;29:1401-1404.
81. Treves TA, Bornstein NM, Chapman J, et al. APOEepsilon 4 in patients with Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1996;10:189-191.
82. Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S. Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol Dis 1999;6:508-514.
83. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-46.
84. Ehnholm C, Lukka M, Kuusi T, Nikkila E, Uterman G. Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
85. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Int Med 2002;137:149-155.
86. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-1206.
87. Roses AD. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer's disease. Arch Neurol 2010;67:536-541.
88. Lutz MW, Crenshaw DG, Saunders AM, Roses AD. Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement 2010;6:125-131.
89. Breteler MMB. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective. Neurobiol Aging 2000;21:153-160.
90. Elkins JS, O'Meara ES, Longstreth WT, Carlson MC, Manolio TA, Johnston SC. Stroke risk factors and loss of high cognitive function. Neurology 2004;63:793-799.
91. Qiu C, Winblad, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-499.
92. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ. Change in blood pressure and incident dementia: A 32-year prospective study. Hypertension 2009;54:233-240.
93. Petrovitch H, White LR, Izmirilian G, et al; Honolulu-Asia Aging Study Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Neurobiol Aging 2000;21:57-62.
94. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006;2:CD004034.
95. Borenstein AR, Wu Y, Mortimer JA, et al. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 2005;26:325-334.
96. Meyer JS, Rauch GM, Crawford K, et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 1999;14:1050-1061.
97. Meyer JS, Rauch G, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment and dementia. Neurobiol Aging 2000;21:161-169.
98. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann NY Acad Sci 2000;903:411-423.
99. Miyasaka Y, Barnes ME, Petersen RC, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: Data from a community-based cohort. Eur heart J 2007;28:1962-1967.
100. Rastas S, Verkkoniemi A, Polvikoski T, et al. Atrial fibrillation, stroke, and cognition: A longitudinal population-based study of people aged 85 and older. Stroke 2007;38:1454-1460.
101. Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998;29:2087-2093.
102. Bejot Y, Ben Salem D, Osseby GV, et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985-2006. Neurology 2009;72:346-353.
103. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42-48.
104. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study. Diabetes 2009;58:71-77.
105. Roberts RO, Geda YE, Knopman DS, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008;65:1066-1073.
106. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006;67:1960-1965.
107. Pappolla MA, Bryant-Thomas TK, Herbert D, et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 2006;61:199-205.
108. Li G, Shofer JB, Rhew IC, et al. Age-varying association between statin use and Alzheimer's disease. J Am Geriatr Soc 2010;58:1393-1394.
109. Graves A, van Duijn C, Chandra V, et al; EURODEM Risk Factors Research Group. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(Suppl 2):548-557.
110. Launer L, Andersen K, Dewey ME, et al.; for the EURODEM Incidence Research Group and Work Groups. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. Neurology 1999;52:78-84.
111. Tyas SL, White LR, Petrovitch H, Webster Ross G, Foley DJ, Heimovitz HK, Launer LJ. Mid-life smoking and late-life dementia: The Honolulu-Asia Aging Study. Neurobiol Aging 2003;24:589-596.
112. Kivipelto M, Rovio S, Ngandu T, et al. Apolipoprotein E epsilon-4 magnifies lifestyle risks for dementia: A population-based study. J Cell Mol Med 2008;12:2762-2771.
113. Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K. Predicting risk of dementia in older adults. The late-life dementia risk index. Neurology 2009;73:173-179.
114. Loeb C, Meyer JS. Vascular dementia: Still a debatable entity? J Neurol Sci 1996;143:31-40.
115. Andin U, Gustafson L, Brun A, Passant U. Clinical manifestations in neuropathologically defined subgroups vascular dementia. Int J Geriatr Psychiatry 2006;21:688-697.
116. Desmond DW. Vascular dementia: A construct in evolution. Cerebrovasc Brain Metab 1996;8:296-325.
117. Merino JG. Dementia after stroke: High incidence and intriguing associations. Stroke (Editorial Comment) 2002;33:2261-2262.
118. Korczyn AD. Alzheimer's disease and vascular lesions. J Neurol Sci 2005;231:1-2.
119. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
120. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
121. Mura T, Dartigues J-F, Berr C. How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050. Eur J Neurol 2009;17:252-259.
122. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998;17:2-9.
123. Davies AR, Smeeth L, Grundy EMD. Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996-2005. Eur Heart J 2007;28:2142-2147.
124. Leys D, Pasquier F, Parnetti L. Epidemiology of vascular dementia. Haemostasis 1998;28:134-150.
125. Deschaintre Y, Richard F, Leys D, Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer's disease. Neurology 2009;73:674-680.